CoChat

TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD

Open access

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver pathology worldwide. In mice and humans, NAFLD progression is characterized by the appearance of TREM2-expressing macrophages in the liver. However, their mechanistic contributions to disease progression have not been completely elucidated. Here, we show that TREM2+ macrophages prevent the generation of a pro-inflammatory response elicited by LPS-laden lipoproteins in vitro. Further, Trem2 expression regulates bone-marrow-derived macrophages (BMDMs) and Kupffer cell capacity to phagocyte apoptotic cells in vitro, which is dependent on CD14 activation. In line with this, loss of Trem2 resulted in an increased pro-inflammatory response, which ultimately aggravated liver fibrosis in murine models of NAFLD. Similarly, in a human NAFLD cohort, plasma levels of TREM2 were increased and hepatic TREM2 expression was correlated with higher levels of liver triglycerides and the acquisition of a fibrotic gene signature. Altogether, our results suggest that TREM2+ macrophages have a protective function during the progression of NAFLD, as they are involved in the processing of pro-inflammatory lipoproteins and phagocytosis of apoptotic cells and, thereby, are critical contributors for the re-establishment of liver homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells12030341

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 LPS-containing TRLs elicit a macrophage-dependent pro-inflammatory response in the liver (a) LPS levels were measured in serum and TRL particles isolated from healthy and obese patients (n = 6). (b–e) Mice were pre-treated or not with clodronate to deplete macrophages and then injected without or with LPS-containing TRL particles. Liver tissue was harvested 4 h after injection. Hepatic gene expression of Tnfa (b), Il1b (c), Il6 (d) and Trem2 (e) (n = 5–6). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by two-way ANOVA and are indicated as p-value (a) or as different letters (b–e).
Figure 1 LPS-containing TRLs elicit a macrophage-dependent pro-inflammatory response in the liver (a) LPS levels were measured in serum and TRL particles isolated from healthy and obese patients (n = 6). (b–e) Mice were pre-treated or not with clodronate to deplete macrophages and then injected without or with LPS-containing TRL particles. Liver tissue was harvested 4 h after injection. Hepatic gene expression of Tnfa (b), Il1b (c), Il6 (d) and Trem2 (e) (n = 5–6). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by two-way ANOVA and are indicated as p-value (a) or as different letters (b–e).CC BY · PubMed Central
Figure 2 Trem2 controls LPS- and TRL-induced hepatic pro-inflammatory response (a–c) WT (Trem2+/+) and Trem2−/− mice were injected with TRL particles. (a) Western blot of JNK1 and JNK2 as well as phosphorylated JNK1 and JNK2 and (b) its quantification (n = 4). (c) Hepatic gene expression of Tnfa, Il1b and Il6 (n = 7). (d) KC from WT (Trem2+/+) and Trem2−/−mice were treated with LPS and secretion of TNFα, IL1β and IL6 into the media was measured after 4 and 18 h (n = 4). (e) Gene expression of Lpl, Cd36 and Lipa in WT (Trem2+/+) and Trem2−/− BMDMs. (f) Uptake of DiD-labeled TRL particles into WT (Trem2+/+) and Trem2−/− macrophages (n = 9–10). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test (a–e) or Mann–Whitney test (f) and are indicated as p-value.
Figure 2 Trem2 controls LPS- and TRL-induced hepatic pro-inflammatory response (a–c) WT (Trem2+/+) and Trem2−/− mice were injected with TRL particles. (a) Western blot of JNK1 and JNK2 as well as phosphorylated JNK1 and JNK2 and (b) its quantification (n = 4). (c) Hepatic gene expression of Tnfa, Il1b and Il6 (n = 7). (d) KC from WT (Trem2+/+) and Trem2−/−mice were treated with LPS and secretion of TNFα, IL1β and IL6 into the media was measured after 4 and 18 h (n = 4). (e) Gene expression of Lpl, Cd36 and Lipa in WT (Trem2+/+) and Trem2−/− BMDMs. (f) Uptake of DiD-labeled TRL particles into WT (Trem2+/+) and Trem2−/− macrophages (n = 9–10). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test (a–e) or Mann–Whitney test (f) and are indicated as p-value.CC BY · PubMed Central
Figure 3 Trem2 regulates KC-dependent uptake of apoptotic cells (a) KCs were isolated from WT (Trem2+/+) and Trem2−/− mice and incubated with labeled aHs at 4 °C (binding control) and 37 °C (binding+uptake); (left panel): gating strategy, (right panel): quantification of phagocyting macrophages (n = 4–5). (b) BMDMs were isolated from WT (Trem2+/+) and Trem2−/− mice and incubated with labeled apoptotic hepatocytes at 4 °C (binding control) and at 37 °C (uptake); (left panel): gating strategy (right panel): quantification of phagocyting macrophages (n = 5–6). (c) Hepatic macrophages were isolated from WT (Trem2+/+) and Trem2−/− mice, pre-treated with control (IgG) or anti-CD14 antibody (aCD14), stimulated with LPS for 20 h and incubated with labeled aHs. Phagocyting macrophages were quantified (n = 8). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Mann–Whitney test (a,b) and Student’s t-test (c) and are indicated as p-value.
Figure 3 Trem2 regulates KC-dependent uptake of apoptotic cells (a) KCs were isolated from WT (Trem2+/+) and Trem2−/− mice and incubated with labeled aHs at 4 °C (binding control) and 37 °C (binding+uptake); (left panel): gating strategy, (right panel): quantification of phagocyting macrophages (n = 4–5). (b) BMDMs were isolated from WT (Trem2+/+) and Trem2−/− mice and incubated with labeled apoptotic hepatocytes at 4 °C (binding control) and at 37 °C (uptake); (left panel): gating strategy (right panel): quantification of phagocyting macrophages (n = 5–6). (c) Hepatic macrophages were isolated from WT (Trem2+/+) and Trem2−/− mice, pre-treated with control (IgG) or anti-CD14 antibody (aCD14), stimulated with LPS for 20 h and incubated with labeled aHs. Phagocyting macrophages were quantified (n = 8). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Mann–Whitney test (a,b) and Student’s t-test (c) and are indicated as p-value.CC BY · PubMed Central
Figure 4 Loss of Trem2 results in the accumulation of apoptotic cells and aggravates liver damage. (a) Western Blotdepicting CASPASE 3 and cleaved CASPASE 3 levels as a marker for hepatic apoptosis and (b) quantification of cleaved CASPASE 3 expression (n = 4) and (c) gene expression of Bax performed on liver samples isolated from of WT (Trem2+/+) and Trem2−/− mice (n = 4). WT (Trem2+/+) and Trem2−/− mice were fed with an HFD and (d) the frequency of hepatic apoptotic cells detected by Annexin V staining (n = 6), and (e) frequency of differentially polarized macrophage populations is shown (n = 6). (f–m). WT (Trem2+/+) and Trem2−/− mice as well as WT (Trem2+/+) and Trem2−/− mice deficient for Apoe were fed a HFD for 16 weeks. (f) Body weight, (g) liver weight, (h) liver triglyceride (TG) levels, (i) H&E staining of liver sections (scale bar = 200 µm), (j) plasma ALT levels, hepatic gene expression of (k) Tgfb1 and (l) Col1a1 (n = 5–8) and (m) Sirius red staining of liver sections (scale bar = 200 µm). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test (b,c,f–h,j–l) and Mann–Whitney test (d,e) and are indicated as p-value.
Figure 4 Loss of Trem2 results in the accumulation of apoptotic cells and aggravates liver damage. (a) Western Blotdepicting CASPASE 3 and cleaved CASPASE 3 levels as a marker for hepatic apoptosis and (b) quantification of cleaved CASPASE 3 expression (n = 4) and (c) gene expression of Bax performed on liver samples isolated from of WT (Trem2+/+) and Trem2−/− mice (n = 4). WT (Trem2+/+) and Trem2−/− mice were fed with an HFD and (d) the frequency of hepatic apoptotic cells detected by Annexin V staining (n = 6), and (e) frequency of differentially polarized macrophage populations is shown (n = 6). (f–m). WT (Trem2+/+) and Trem2−/− mice as well as WT (Trem2+/+) and Trem2−/− mice deficient for Apoe were fed a HFD for 16 weeks. (f) Body weight, (g) liver weight, (h) liver triglyceride (TG) levels, (i) H&E staining of liver sections (scale bar = 200 µm), (j) plasma ALT levels, hepatic gene expression of (k) Tgfb1 and (l) Col1a1 (n = 5–8) and (m) Sirius red staining of liver sections (scale bar = 200 µm). Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test (b,c,f–h,j–l) and Mann–Whitney test (d,e) and are indicated as p-value.CC BY · PubMed Central
Figure 5 TREM2 in human NAFLD. (a) Levels of soluble TREM2 in human healthy controls or NASH patients (n = 19–21). (b–d) Correlation of hepatic TREM2 expression with (b) plasma ALT levels, (c) hepatic COL1A1 and (d) liver triglyceride (TG) levels in a human cohort (n= 120). (a) Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test and are indicated as p-value. (b–d) Correlation is given as Pearson R.
Figure 5 TREM2 in human NAFLD. (a) Levels of soluble TREM2 in human healthy controls or NASH patients (n = 19–21). (b–d) Correlation of hepatic TREM2 expression with (b) plasma ALT levels, (c) hepatic COL1A1 and (d) liver triglyceride (TG) levels in a human cohort (n= 120). (a) Data are shown as mean + SEM. Statistically significant differences between groups (p < 0.05) were determined by Student’s t-test and are indicated as p-value. (b–d) Correlation is given as Pearson R.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

Metadata

Authors
Liebold, I., Meyer, S., Heine, M., Kuhl, A., Witt, J., Eissing, L., Fischer, A., Koop, A., Kluwe, J., Schulze zur Wiesch, J., Wehmeyer, M., Knippschild, U., Scheja, L., Heeren, J., Bosurgi, L., & Worthmann, A.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • Harvard University (US)
  • I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
  • University Hospital Ulm (DE)
  • Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Corresponding author
  • Bosurgi, Lidia
  • Worthmann, Anna
Venue
Cells
Publisher
MDPI AG
Published
2023-01-17
Volume
12
Issue
3
Pages
341
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4316673371
Cited by
55
References
54
Citations by year
2026: 19 · 2025: 22 · 2024: 10 · 2023: 4
FWCI
10.94
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • DFG (450149205-TRR333/1, LFF-FV75)
  • State of Hamburg (450149205-TRR333/1, LFF-FV75)
  • Mühlbauer-fundation (450149205-TRR333/1, LFF-FV75)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
TREM2, non-alcoholic fatty liver disease, TREM2+ macrophages, Kupffer cells, bone marrow-derived macrophages, phagocytosis of apoptotic cells, CD14, pro-inflammatory response, liver fibrosis, liver inflammation, hepatic triglycerides, liver homeostasis
MeSH terms
Animals, Humans, Liver Cirrhosis, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, Apoptosis, Mice, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.